Mondello, P., Derenzini, E., Asgari, Z., Philip, J., Brea, E. J., Seshan, V., . . . Younes, A. (2017). Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma. Oncotarget.
शिकागो स्टाइल उद्धरणMondello, Patrizia, et al. "Dual Inhibition of Histone Deacetylases and Phosphoinositide 3-kinase Enhances Therapeutic Activity against B Cell Lymphoma." Oncotarget 2017.
एमएलए उद्धरणMondello, Patrizia, et al. "Dual Inhibition of Histone Deacetylases and Phosphoinositide 3-kinase Enhances Therapeutic Activity against B Cell Lymphoma." Oncotarget 2017.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.